Non-invasive diagnostic imaging tests largely underdiagnose cardiac cirrhosis in patients undergoing advanced therapy evaluation: How can we identify the high-risk patient?
David BelzilePierre Yves TurgeonEvelyne LeblancMontse MassotChristine BourgaultJoёlle MorinCéline DupuisMarc BilodeauMaxime LaflammeEric CharbonneauSylvain TrahanSylvain PagéPhilippe JoubertChristian CoutureMario SénéchalPublished in: Clinical transplantation (2021)
Ultrasonography has the best-combined sensitivity and specificity for the diagnosis of cirrhosis. However, more than a third of patients with cirrhosis will go undiagnosed by conventional imaging. As liver biopsy is associated with a low rate of complication, it should be considered in patients with a high-risk of cirrhosis or with evidence of portal hypertension to assess their eligibility for heart transplantation or LVAD implantation.